Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06773962 · ClinicalTrials.gov registry record · Phase 2
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease
A Phase 2 study of Parkinsons Disease (PD), sponsored by TrueBinding.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 62
- Enrollment target
- 14
- Study locations
NCT06773962 is a Phase 2 study of Parkinsons Disease (PD) that is actively recruiting participants, run by TrueBinding. The registered enrollment target is 62 participants, below the 116-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (47% lower). The trial reports 14 study locations across 10 states.
The verdict
NCT06773962, a Phase 2 study of Parkinsons Disease (PD), is actively recruiting participants, sponsored by TrueBinding.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 62 participants
- Enrollment target
- 14
- Study locations
Study Summary
The primary objectives of this study are to assess the efficacy of TB006 in improving motor function and to assess the safety of TB006 in participants with Parkinson's Disease (PD).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG TB006
Study Locations (14)
Florida
- Parkinson's Disease and Movement Disorders Center of Boca Raton - Boca Raton
- University of Miami - Miami
- University of South Florida Parkinson's and Movement Disorders Center - Tampa
California
- Parkinson's Research Centers of America - Orange County - Aliso Viejo
- Parkinson's Research Centers of America - Palo Alto - Palo Alto
New York
- Parkinson's Research Centers of America - Long Island - Commack
- NYU Langone Health - Patchogue
Colorado
- CenExel Rocky Mountain Clinical Research - Englewood
Illinois
- Consultants in Neurology, Ltd - Northbrook
Indiana
- Josephson Wallack Munshower Neurology - Southeast - Indianapolis
Kansas
- University of Kansas Medical Center - Kansas City
Michigan
- Quest Research Institute - Farmington Hills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2025-03-20 |
| Est. Completion | 2026-09-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06773962
The ClinicalTrials.gov registry entry for NCT06773962 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 116-participant average among 19 other Parkinsons Disease (PD) trials with a reported enrollment target (47% lower). The listed sponsor is TrueBinding, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Parkinsons Disease (PD) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06773962 reports 14 study locations spanning 10 distinct geographic areas - top geographies include Florida, California, New York.
Frequently Asked Questions
What is clinical trial NCT06773962 about?
NCT06773962 is a clinical study titled "A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's Disease". The primary objectives of this study are to assess the efficacy of TB006 in improving motor function and to assess the safety of TB006 in participants with Parkinson's Disease (PD).
What is the current status of trial NCT06773962?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 62 participants. The study started on 2025-03-20. Estimated completion is 2026-09-01.
What conditions does trial NCT06773962 study?
This clinical trial studies the following conditions: Parkinsons Disease (PD).
What interventions are being tested in trial NCT06773962?
The interventions under investigation include: Placebo (DRUG), TB006 (DRUG).
Who is sponsoring clinical trial NCT06773962?
This trial is sponsored by TrueBinding, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06773962 being conducted?
This trial has 14 study locations across California, Colorado, Florida, Illinois, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinsons Disease (PD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of NE3107 in Early Parkinson's
RECRUITING · Phase 2
-
A Study of Buntanetap in Participants With PD
RECRUITING · Phase 2
-
Transcranial Direct Current Stimulation for Motor Function and Fatigue in PD
RECRUITING · NA
-
Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations
RECRUITING · NA
-
Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.
RECRUITING · Phase 1
-
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.